Clinical trial
Study of Paclitaxel, Carboplatin, and Cetuximab for Advanced Lung Cancer
NCT00315185 · Fox Chase Cancer Center, Other · Completed
Key facts
| NCT number | NCT00315185 |
|---|---|
| Title | Study of Paclitaxel, Carboplatin, and Cetuximab for Advanced Lung Cancer |
| Official title | Phase II Study as First Line Treatment for Patients With Advanced Non-Small Cell Lung Cancer |
| Lead sponsor | Fox Chase Cancer Center, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Carcinoma, Non-Small-Cell Lung |
| Intervention type | Drug |
| Interventions | Cetuximab |
| Enrollment | 53 |
| Start date | Dec 1, 2004 |
| Primary completion | Jun 1, 2007 |
| Completion | Jun 1, 2008 |
| First posted | Apr 18, 2006 |
| Last update posted | Sep 23, 2010 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: